BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10575181)

  • 1. Circadian blood pressure changes and cardiac abnormalities in IgA nephropathy.
    Szelestei T; Kovács T; Barta J; Nagy J
    Am J Nephrol; 1999; 19(5):546-51. PubMed ID: 10575181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy.
    Csiky B; Kovács T; Wágner L; Vass T; Nagy J
    Nephrol Dial Transplant; 1999 Jan; 14(1):86-90. PubMed ID: 10052483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
    Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K
    Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure control in a hypertension hospital clinic.
    Cuspidi C; Lonati L; Sampieri L; Macca G; Valagussa L; Zaro T; Michev I; Salerno M; Leonetti G; Zanchetti A
    J Hypertens; 1999 Jun; 17(6):835-41. PubMed ID: 10459882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between left ventricular mass and blood pressure in treated hypertension.
    Missault LH; De Buyzere ML; De Bacquer DD; Duprez DD; Clement DL
    J Hum Hypertens; 2002 Jan; 16(1):61-6. PubMed ID: 11840231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A double ambulatory product (blood pressure and heart rate), mild arterial hypertension and left ventricular hypertrophy].
    Azevedo J; Arroja I; Jacques A; Santos I; Amado P; Marques JC; Araújo V
    Rev Port Cardiol; 1993; 12(7-8):663-73, 602. PubMed ID: 8352987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.
    Devereux RB; Palmieri V; Sharpe N; De Quattro V; Bella JN; de Simone G; Walker JF; Hahn RT; Dahlöf B
    Circulation; 2001 Sep; 104(11):1248-54. PubMed ID: 11551875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily blood pressure control is not sufficient to regress cardiac hypertrophy and dysfunction: a bi-ventricular tissue Doppler echocardiographic study.
    Balal M; Koc M; Paydas S; Demir E; Sertdemir Y; Acarturk E
    Nephrology (Carlton); 2007 Apr; 12(2):140-6. PubMed ID: 17371336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria, pulse pressure, left ventricular hypertrophy, and myocardial ultrasonic tissue characterization in essential hypertension.
    Di Bello V; Pedrinelli R; Giorgi D; Bertini A; Caputo MT; Cioppi A; Talini E; Leonardo M; Dell'Omo G; Paterni M; Giusti C
    Angiology; 2001 Mar; 52(3):175-83. PubMed ID: 11269780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis.
    Stefanski A; Schmidt KG; Waldherr R; Ritz E
    Kidney Int; 1996 Oct; 50(4):1321-6. PubMed ID: 8887294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension.
    Belsha CW; Wells TG; McNiece KL; Seib PM; Plummer JK; Berry PL
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):410-7. PubMed ID: 9607378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.
    Tumuklu MM; Erkorkmaz U; Ocal A
    Echocardiography; 2007 Apr; 24(4):374-84. PubMed ID: 17381646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure levels and variability, smoking, and left ventricular structure in normotension and in borderline and mild hypertension.
    Majahalme S; Turjanmaa V; Weder A; Lu H; Tuomisto M; Virjo A; Uusitalo A
    Am J Hypertens; 1996 Nov; 9(11):1110-8. PubMed ID: 8931837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril and diltiazem reduce left ventricular mass without changing blood pressure in normotensive subjects with exaggerated blood pressure response to exercise.
    Polónia J; Martins L; Macedo F; Faria DB; Simões L; Brandão F; Gomes MC
    Rev Port Cardiol; 1996 Mar; 15(3):185-93, 179. PubMed ID: 8634167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power spectral analysis of the heart rate in hypertensive patients with and without left ventricular hypertrophy: the effect of a left ventricular mass reduction.
    Muiesan ML; Rizzoni D; Zulli R; Castellano M; Bettoni G; Porteri E; Agabiti-Rosei E
    J Hypertens; 1998 Nov; 16(11):1641-50. PubMed ID: 9856365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.